chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Information has been received from a physician concerning a female employee who "about 15 years ago", in approximately 1996, was vaccinated with a dose of RECOMBIVAX HB (Lot # not provided). It was reported the patient who received RECOMBIVAX HB subsequently experienced neck pain on the same side as the injection site "about 15 years ago", in approximately 1996. Whether the patient sought medical attention was not reported. At the time of reporting, the patient's outcome was unknown. Additional information has been requested.
my asthma and allergies seemed to be triggered; chills; dizziness; chest pains; feeling of nausea; abdominal pain; bad headache/Today my head continues to hurt but my asthma and allergies seemed to be triggered; cold sweats; shortness of breath; diarrhea; This is a spontaneous report from a contactable consumer or other non hcp.  A 51-years-old female Non Pregnant patient received bnt162b2 (BNT162B2), dose 1 via an unspecified route of administration, administered in Arm Right on 21Sep2021 09:00 (Batch/Lot Number: Fe3592) as dose 1, single for covid-19 immunisation. Medical history included large intestine polyp, cough, dyspepsia, thyroid disorder, asthma, hypertension, iodine allergy. Concomitant medication(s) included hydrochlorothiazide, losartan potassium (LOSARTAN/HCT). The patient previously took codeine and experienced drug hypersensitivity, Percocet [oxycodone hydrochloride; oxycodone terephthalate; paracetamol] and experienced drug hypersensitivity, prednisone and experienced drug hypersensitivity.  The patient did not receive any other vaccine in four weeks. Prior to vaccination patient was not diagnosed with COVID. Post vaccination patient did not test for COVID. It was reported that, the patient experienced chills, dizziness, chest pains, feeling of nausea, abdominal pain, bad headache/today my head continues to hurt but my asthma and allergies seemed to be triggered, cold sweats, shortness of breath, diarrhoea, my asthma and allergies seemed to be triggered on 24Sep2021 with outcome of recovering. Treatment received for the adverse event Toradol, Reglan, Zofran, ECG 12 Lead, Lab test, Pretherapeutic measures were taken as a result of chills (chills), dizziness (dizziness), chest pains (chest pain), feeling of nausea (nausea), abdominal pain (abdominal pain), bad headache/today my head continues to hurt but my asthma and allergies seemed to be triggered (headache), cold sweats (cold sweat), shortness of breath (dyspnoea), diarrhoea (diarrhoea), my asthma and allergies seemed to be triggered (condition aggravated).  Follow-up attempts are completed. No further information is expected.
vaccinated with pfizer in April 2021- Said he is feeling fine and has no symptoms.
Patient received immunizations and then waited in room for school forms. When patient was waiting for form he developed facial and torso rash, was itchy and had red eyes was sent to hospital for further evaluation.
Information has been received from a registered nurse concerning a 66 year old male who on 05-MAR-2008, inadvertently was vaccinated with a 0.5 mL subcutaneous dose of in the left arm of varicella virus vaccine live (Oka/Merck) instead of zoster vaccine live (Oka/Merck). It was indicated by the registered nurse that it was staff error only. The patient had no reported adverse complaints post vaccination. Current patient status was not reported. A product quality complaint was not reported. Additional information has been requested. This is in follow-up to report (s) previously submitted on 5/16/2008.  Initial and follow up information has been received from a registered nurse concerning a 65 year old male who on 05-MAR-2008, inadvertently was vaccinated with a 0.5 ml, subcutaneous dose in the left arm of varicella virus vaccine live (Merck) (Lot # 658052/1008U) instead of zoster vaccine live (Merck) (MSD).  It was indicated by the registered nurse that it was staff error only.  The patient had no reported adverse complaints post vaccination.  Current patient status was not reported.  A product quality complaint was not reported.  Additional information has been requested.
He was sick with COVID  like symptoms for approx. 2-3 days; He was sick with COVID  like symptoms for approx. 2-3 days; He was sick; This is a spontaneous report from a contactable consumer. The consumer reported events for both doses of vaccine. This is the first of two reports.  A male patient of unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), dose 1 via an unspecified route of administration on Apr2021 (Batch/Lot number was not reported) as single dose for covid-19 immunisation. The patient medical history and the patient's concomitant medications were not reported. The patient experienced who he was sick with covid like symptoms for approximately 2-3 days on Apr2021 with outcome of unknown.  The lot number for the vaccine, BNT162B2, was not provided and will be re-quested during follow up. Sender's Comments: Linked Report(s): US-PFIZER INC-202101138967 Same patient/ drug and different events separated by dose.
Patient's wife reported that the day after receiving his second Shingrix dose the injection site arm swelled and the area was red, hot to the touch, and itchy. The patient applied Cerave itch lotion to the area.  The rash/swelling/itching is resolving.
Shortness of breath, elevated heart rate, pneumonia, fever,  diagnosis of heart failure, hospitalization and prescription of drugs to address
The patient has received the full COVID vaccine series and has been hospitalized.  Per the H&P 1/15/2022 9:44        Abdominal pain/constipation      History of Present Illness  Pleasant 96-year-old female who is well-known to my partner doctor  She has a history of arthritis chronic low back pain on chronic pain medicines atrial fibrillation lower GIB bleed admitted September 2021 pulmonary hypertension aortic stenosis and mitral regurgitation.  She was having some abdominal pain it appears the abdominal pain is in the right lower quadrant she also has generalized pain and is currently complaining of pain in her right shoulder in addition.  She states she has not had a bowel movement in 6 days and we do not feel she has had a bowel movement since she has been to the emergency room.  She is tolerating her diet.  No nausea or vomiting.  - Unknown vaccine manufacturer, date, and location received.
This spontaneous report was received from a physician via company representative refers to a female patient of unknown age. There was no drug allergies. On an unknown date, the patient was vaccinated with first dose of GARDASIL, (lot number, expiry date was not reported). On an unknown date, the patient after vaccination within a minute developed erythema. Subsequently erythema cleared within a day. The outcome of the event was reported as recovered. The patient sought medical attention. Additional information has been requested.
Spike in BP143/98, unusual feeling in throat, 50mg of Benadryl administered with water, pt BP came down to 124/82 HR 89 O2 97%, The doctor on site is monitoring her
Diarrhea, cold sweat at night, headache, eyes slightly swollen. At first was abdominal pain coupled with diarrhea. For the past week, I have been having cold sweats at night but no fever that I have been able to record. Sore throat, slight cough, and headaches also in this past week.
"Deep in my arm pit"-almost chest area of left side (same as injection), extremely tender. Hurts/aches all the time. Hurts to raise arm overhead x 4 days. Tightness, left lwr back-spasm. Has a Dr's appt 11/2/99. Labs drawn 11/4/99.
Client complained of joint pain in his right forefinger and right big toe. Stated his toe started hurting back in Jan 2002. He had the 1st 3 shots of Anthrax in 2000. Last year he went to Doctor saying it was hard to walk on his toe. Client states the pain is getting worse in his toe and finger, wants to know if it is related to the Anthrax shot. Patient stated he started having pain in his toe around Jan 2002 and not progressively worse.
pt recvd vax & 6 hrs p/vax pt had 4 1/2 hrs of high pitched crying, inconsolable crying, jitteriness, hyperexcitability; this cont for 3 more days w/alternating periods of excessive somnolence;
Itching; Hard injection site; arm got sore; Swollen injection site; Slept all day and all night; Headache which got worse during the day; Fever; Felt tired; This case was initially received via an unknown source (no reference has been entered for a health authority or license partner) on 26-Feb-2021. The most recent information was received on 16-Jul-2021 and was forwarded to Moderna on 16-Jul-2021.    This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm got sore), VACCINATION SITE SWELLING (Swollen injection site), SOMNOLENCE (Slept all day and all night), PRURITUS (Itching) and VACCINATION SITE INDURATION (Hard injection site) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 023M20A and 029L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Macular degeneration. Concomitant products included SIMVASTATIN, VIT D [VITAMIN D NOS], CYANOCOBALAMIN (B 12) and MULTIVITAMIN & MINERAL for an unknown indication.   On 23-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced SOMNOLENCE (Slept all day and all night), HEADACHE (Headache which got worse during the day), PYREXIA (Fever) and FATIGUE (Felt tired). On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (arm got sore), VACCINATION SITE SWELLING (Swollen injection site), PRURITUS (Itching) and VACCINATION SITE INDURATION (Hard injection site). The patient was treated with PARACETAMOL (TYLENOL) (oral) at a dose of 1 dosage form. On 25-Feb-2021, PRURITUS (Itching) had resolved. At the time of the report, PAIN IN EXTREMITY (arm got sore), VACCINATION SITE SWELLING (Swollen injection site), SOMNOLENCE (Slept all day and all night), VACCINATION SITE INDURATION (Hard injection site), HEADACHE (Headache which got worse during the day), PYREXIA (Fever) and FATIGUE (Felt tired) had resolved.            Concomitant medications included Eye vitamin for macular degeneration.   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 16-Jul-2021: Form added - she said that she is fine now so she declined further FU. Out come of the Events updated .Follow up correspondence attached.
Information has been received from a pharmacist concerning a female physician who on an unspecified date was vaccinated with VARIVAX (Oka/Merck) or with ZOSTAVAX (Oka/Merck) (MSD). The pharmacist reported that she is not actively working outside the home but a friend consulted her about transmissibility of Varicella. The pharmacist's friend disclosed her female doctor was vaccinated with VARIVAX, unknown if VARIVAX (Oka/Merck) or ZOSTAVAX (Oka/Merck) (MSD) and had a rash. The physician told this person not to worry she was not contagious. But her friend was not so sure. The patient's outcome was unknown. No further information is available.
First Covid Shot. Friday. Muscular ache by end of day. Went to bed early. Woke up with pain across shoulders and down left side stayed in bed. Six spasm in left side back began to spasm. 9 went to hospital as breathing became labored and spasm become  intense
Intussusception with vomiting, lethargy.  6/5/07 Received vax records from PCP which confirms lot & dose # on report. Vax record faxed to CDC.  10/16/07 Received hospital medical records which reveal patient experienced irritability, decreased oral intake, tender abdomen, listlessness, vomiting & nonbloody diarrhea x 1 day.  Had sick contact with viral enteritis.  Saw pcp who palpated mass in RUQ & sent to ER.  Admitted 5/15-5/16/2007 for overnight observation s/p reduction of IS.  Progressed well & d/c to home. FINAL DX: ileocecal intussusception, enema reduced.  Records faxed to CDC.
Developed a red itchy rash below the injection site from mid arm to wrist area. warm to the touch and itchy.
Patient claims after the 15 minute observation time that she had tingling in both arms. She claims never to have felt this before. She was asked if she felt short of breath, itchy, or dizzy to which she responded "no". She was asked to sit down for observation, rescue was called and arrived on scene. Patient was fine at the time rescue came, her blood pressure was high and she refused to be taken to the hospital.
Patient was seen in office for 6 month vaccines at 09:45am on 01/22/19. Patient tolerated well and left office. Per Urgent care documentation: Patient presented to Urgent Care with complaints of seizure like activity and fever starting around 3:00pm. Patient was monitored at urgent care and had a witnessed seizure and one episode of vomiting. After consultation among physicians patient was transferred to emergency department in the same facility and then transferred to a high level of care facility.
Patient was waiting being monitored. Initially she was standing. About 10 minutes into monitoring, she became light headed, described her vision as "going black for a moment".  She was seated, given a wet paper towel for her neck and water to drink. Blood pressure was checked at 12:12 pm: 74/52 and again at 12:25 pm: 109/81. patient was monitored for about 10 more minutes and felt fine to leave. At 5pm, I called to check on patient and she said she was feeling much better with no issues.
Patient got second dose of Pfizer Covid 19 vaccine. After verifying patient did not have any reaction to the first dose, the second dose was administered. Patient was really nervous to begin with. After receiving second dose within 2-3 minutes patient fell from chair face on hitting her head against the floor and a minor cut on the outer eye was observed. The arms and neck area broke out into rash. I gave her a benadryl tablet, tylenol for the fall, and we iced the eye and monitored patient for 30 minutes. The patient's mom took her to the ER where she was getting a CT scan done for the eye.
Drug ineffective; COVID/Feeling sick/not feeling well; This spontaneous case was reported by a consumer and describes the occurrence of COVID-19 (COVID/Feeling sick/not feeling well) and DRUG INEFFECTIVE (Drug ineffective) in a 65-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product ADALIMUMAB (HUMIRA) solution for injection for Rheumatoid arthritis.    Concurrent medical conditions included Rheumatoid arthritis (Moderate to severe rheumatoid arthritis).   On 05-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 01-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Dec-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient started ADALIMUMAB (HUMIRA) (Subcutaneous) 1 dosage form. On 16-Aug-2022,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced COVID-19 (COVID/Feeling sick/not feeling well). On an unknown date, the patient experienced DRUG INEFFECTIVE (Drug ineffective). At the time of the report, COVID-19 (COVID/Feeling sick/not feeling well) and DRUG INEFFECTIVE (Drug ineffective) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 19-Aug-2022, SARS-CoV-2 test: (Positive) Positive.         Concomitant product use was not provided. Treatment information was not provided.  It was unknown if patient was enrolled in a COVID-19 vaccine trial.  The reporter's causality for the events of COVID and feeling sick/not feeling well was not provided for Humira.  Company comment- This spontaneous case concerns a 65-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious COVID-19 (with a positive SARS-CoV-2 test dose 2 days after) that occurred 7 months and 26 days after receiving the third dose of mRNA-1273 Vaccine.  Additionally, Drug ineffective was also reported.  The interval between the first and second doses of mRNA was noted to be 27 days. Outcome of the event was not recovered at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.; Sender's Comments: This spontaneous case concerns a 65-year-old female patient with no relevant medical history, who experienced the unexpected, non-serious COVID-19 (with a positive SARS-CoV-2 test dose 2 days after) that occurred 7 months and 26 days after receiving the third dose of mRNA-1273 Vaccine.  Additionally, Drug ineffective was also reported.  The interval between the first and second doses of mRNA was noted to be 27 days. Outcome of the event was not recovered at the time of this report. The benefit-risk relationship of mRNA-1273 Vaccine is not affected by this report.
No symptoms day of or following, maybe the slightest soreness at injection site. 6 days later (Tues 4/27) I began developing severe hives all over my legs, butt, up on hips. Benadryl helped quell, but they keep flaring up. Went to Urgent Care on 4/28 she instructed me to take 2 Benadryl or Vistaril 3X daily, 2-Pepcid OTC 20 mg  daily, and gave me 5 days of two pills daily 40 mg Prednisone.
UTI; Chills; Fever; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI), CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) in an 82-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Mar-2021, the patient experienced CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue). On 22-Mar-2021, the patient experienced URINARY TRACT INFECTION (UTI). At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown and CHILLS (Chills), PYREXIA (Fever) and FATIGUE (Fatigue) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. Treatment information included antibiotics for UTI (urinary tract infection).  The patients chill, fever and fatigue was left after 8 days.   Most recent FOLLOW-UP information incorporated above includes: On 12-May-2021: Contact details of reporter was updated.
Information has been received from a registered nurse concerning a 63 year old male who on 1/25/05 was vaccinated with what was thought to be pneumococcal 23v polysaccharide vaccine. On 2/2/05, the patient was found laying next to his bed and taken to the emergency room where he was diagnosed and admitted with pneumonia. He had a fever of 101.6 upon hospital admission. He was treated with azithromycin and ceftriaxone sodium and recovered. It was noted that no symptoms were exhibited before the patient was found on the floor, and he had no complaints of any illness. The patient is still hospitalized because he fell while in the hospital and was being observed. A product quality complaint was not involved. Additional information has been requested.
Developed red rash 3" diameter around injection site. Area tender/"itchy" as reported by mother.
SICK; UNWELL; TIREDNESS; FEVER; This spontaneous report received from a patient via a company representative concerned a female of unspecified age. The patient's height, and weight were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported.  On an unspecified date, the subject experienced sick, unwell, tiredness, and fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sick, unwell, tiredness, and fever. This report was non-serious. This case, from the same reporter is linked to 20210436316 and 20210436253.
Real bad headache/"Head is killing me"/feels like head is about to explode/Headache/"Head a lot about it"/; 2nd dose not yet received; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Real bad headache/"Head is killing me"/feels like head is about to explode/Headache/"Head a lot about it"/) and PRODUCT DOSE OMISSION ISSUE (2nd dose not yet received) in a 65-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Cholesterol.    On 03-Jul-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced HEADACHE (Real bad headache/"Head is killing me"/feels like head is about to explode/Headache/"Head a lot about it"/) and PRODUCT DOSE OMISSION ISSUE (2nd dose not yet received). The patient was treated with PARACETAMOL (TYLENOL) for Headache, at an unspecified dose and frequency. At the time of the report, HEADACHE (Real bad headache/"Head is killing me"/feels like head is about to explode/Headache/"Head a lot about it"/) had not resolved and PRODUCT DOSE OMISSION ISSUE (2nd dose not yet received) had resolved.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was withdrawn on an unknown date.       no concomitant medication provided.  Patient stated that he took blood pressure and cholesterol medications   Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 17-Aug-2021: Non Significant Information available
During the night I had headache, sore arm, mild nausea. General discomfort. Took a TYLENOL at 600 AM. Symptoms lessened. Generally tired during the day. By 6PM I was back to normal.
Patient developed abdominal cramping and nausea 3 hours after receiving AVA. He was pre-treated with 5 mg of valium for "shot Phobia". Mild headache. Pain 8/10, then dropped to 1-2/10 following antacids. Temperature 99.7 to 97.9, BP 120/80, P83. No vomiting, shortness of breath, diarrhea or diaphoresis. Looked calm, good skin color. Patient has recovered. The cramps lasted approximately 36 hours. Patient also experienced minor chest pain during that time.